Screener
BioSig Technologies, Inc. STEX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: BioSig Technologies, Inc.’s 10-Q, filed August 14, 2026. Open the filing →
- Filed
- Aug 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-038293
FAQ
- What is BioSig Technologies, Inc.'s EPS (diluted)?
- BioSig Technologies, Inc. (STEX) reported EPS (diluted) of -$0.08 in Q2 2026.
- How has BioSig Technologies, Inc.'s EPS (diluted) changed year-over-year?
- BioSig Technologies, Inc.'s EPS (diluted) increased by 89.2% year-over-year, from -$0.74 to -$0.08.
- What is the long-term trend for BioSig Technologies, Inc.'s EPS (diluted)?
- Over 2 years (2023 to 2025), BioSig Technologies, Inc.'s EPS (diluted) has grown at a 54.8% compound annual growth rate (CAGR), from -$4.00 to -$9.58.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about BioSig Technologies, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude